Valid question , I guess it comes back to your risk assessment re commercialisation , and
admittedly I have been looking specifically for some verification / response from the
American Diabetes assoc since PIQ presentation last month .
We ( I ) only have information available at the retail investor level , therefore there is a
requirement for a leap of faith and , imo , there is evidence of things are progressing .....
ie .... all the new coverage by media re Promarker D validation trials , the Indian Proteomics
connections , negotiations re licensing deals ,..the new website .....etc..
While there have been posts about the benefit to individuals re Promarker D testing , imo ,
the greatest benefit will be Govt and Health org. around the globe , ( don't want to be appear
to be insensitive to those individuals ) , this has been explained by PIQ and would seem to be
compelling for Govt and health authorities to at least be doing their due dillegence re the
possibility for some subsidy to individuals taking the test . However Govt are slow movers and
not sure how that will play out ....cheers
glta
PIQ Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)